MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Search

Accuray Inc

Cerrado

SectorSalud

1.32 -2.94

Resumen

Variación precio

24h

Actual

Mínimo

1.32

Máximo

1.38

Métricas clave

By Trading Economics

Ingresos

-3.8M

-1.3M

Ventas

-2.9M

113M

Margen de beneficio

-1.145

Empleados

987

EBITDA

-6.6M

1M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+295.59% upside

Dividendos

By Dow Jones

Próximas Ganancias

13 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-19M

146M

Apertura anterior

4.26

Cierre anterior

1.32

Noticias sobre sentimiento de mercado

By Acuity

40%

60%

119 / 376 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Accuray Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

14 jul 2025, 22:07 UTC

Principales Movimientos del Mercado

Trade Desk Rises on S&P 500 Inclusion

14 jul 2025, 17:06 UTC

Principales Movimientos del Mercado

Crypto Assets Rally Ahead of Possible U.S. Legislation

14 jul 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

NatWest to Sell Stake in Permanent TSB

14 jul 2025, 23:46 UTC

Charlas de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

14 jul 2025, 23:38 UTC

Charlas de Mercado

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14 jul 2025, 23:37 UTC

Charlas de Mercado

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14 jul 2025, 23:29 UTC

Charlas de Mercado

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14 jul 2025, 23:29 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

14 jul 2025, 23:02 UTC

Ganancias

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14 jul 2025, 23:02 UTC

Ganancias

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14 jul 2025, 23:02 UTC

Ganancias

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14 jul 2025, 23:01 UTC

Ganancias

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14 jul 2025, 23:01 UTC

Ganancias

China Vanke Expects 1H Loss to Widen >000002.SZ

14 jul 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

14 jul 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

14 jul 2025, 20:07 UTC

Charlas de Mercado

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14 jul 2025, 20:05 UTC

Charlas de Mercado

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14 jul 2025, 19:11 UTC

Charlas de Mercado

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14 jul 2025, 19:09 UTC

Charlas de Mercado

Gold Breaks a 3-Day Win Streak -- Market Talk

14 jul 2025, 18:59 UTC

Charlas de Mercado

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14 jul 2025, 18:30 UTC

Adquisiciones, fusiones, absorciones

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14 jul 2025, 18:25 UTC

Charlas de Mercado

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14 jul 2025, 18:25 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

14 jul 2025, 16:59 UTC

Charlas de Mercado

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14 jul 2025, 16:53 UTC

Acciones populares

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 jul 2025, 16:27 UTC

Charlas de Mercado

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14 jul 2025, 16:20 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

14 jul 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

14 jul 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

14 jul 2025, 16:12 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Comparación entre iguales

Cambio de precio

Accuray Inc Esperado

Precio Objetivo

By TipRanks

295.59% repunte

Estimación a 12 meses

Media 5.38 USD  295.59%

Máximo 7 USD

Mínimo 4 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Accuray Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

1.28 / 1.61Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

119 / 376 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.